Aditya Ravindra

Accurate quantitative assessment in positron emission tomography (PET) is essential for reliable lesion characterization and therapy response evaluation. Quantitative accuracy is conventionally investigated using physical phantoms or numerical simulations; ho...

To develop and evaluate a radiomic phenotyping and multi-lesion aggregation scheme to derive patient-level biomarkers for identifying progressive disease and predicting time-to-progression (TTP) in diffuse large B-cell lymphoma (DLBCL).